Featured 13F manager
Viking Global Investors LP Andreas Halvorsen
Stamford, CT 22 processed 13Fs on this site · 2021 Q3–2026 Q2
- $35.1B
- 90 Positions
- 2026 Q2
- −1.9% QoQ
- Top 5 21.8%
Portfolio
top 5 21.8% · top 10 35.7%
- V - VISA · CL A 6.2%
- TSM - Taiwan Semiconductor 4.3%
- APD - Air Products 4.0%
- SHW - Sherwin Williams 3.8%
- FTV - Fortive 3.5%
- META - Meta Platforms · CL A 3.0%
- SCHW - Schwab Charles 2.8%
- TMO - Thermo Fisher Scientific 2.8%
- JPM - Jpmorgan Chase & 2.7%
- LII - Lennox Intl 2.6%
- AMZN - Amazon 2.5%
- RACE - Ferrari 2.3%
- Other 59.5%
AUM over time
Book
| V - VISA · CL A | 5.43% | Reduce −18.4% | 5,690,106 | $260.35 | $1.5B | −1,281,229 | −$122M |
| UPS - United Parcel Service · CL B | 4.72% | Add +23.1% | 8,199,127 | $157.23 | $1.3B | +1,538,643 | +$251M |
| APG - API Group | 4.35% | Add +0.3% | 34,302,815 | $34.60 | $1.2B | +103,283 | +$300M |
| WDAY - Workday · CL A | 4.15% | Reduce −21.6% | 4,106,723 | $276.06 | $1.1B | −1,129,921 | +$9M |
| META - Meta Platforms · CL A | 3.88% | Reduce −2.1% | 2,991,633 | $353.96 | $1.1B | −65,389 | +$141M |
| MCK - Mckesson | 3.79% | Add +53.2% | 2,233,205 | $462.98 | $1B | +775,480 | +$400M |
| BBIO - Bridgebio Pharma | 3.71% | Hold | 25,120,991 | $40.37 | $1B | — | — |
| PGR - Progressive | 3.42% | Add +412.0% | 5,863,559 | $159.28 | $934M | +4,718,237 | +$774M |
| DHR - Danaher | 3.39% | Reduce −2.6% | 4,004,517 | $231.34 | $926M | −108,526 | −$94M |
| PM - Philip Morris Intl | 3.32% | Add +61.2% | 9,623,947 | $94.08 | $905M | +3,652,163 | +$353M |
| ROIV - Roivant Sciences | 2.85% | Reduce −5.5% | 69,368,961 | $11.23 | $779M | −4,065,340 | −$79M |
| FTV - Fortive | 2.84% | Add +26.4% | 10,525,824 | $73.63 | $775M | +2,200,729 | +$158M |
| AMZN - Amazon | 2.74% | Reduce −43.7% | 4,929,649 | $151.94 | $749M | −3,820,344 | −$363M |
| AMP - Ameriprise Finl | 2.66% | Add +10.4% | 1,914,374 | $379.83 | $727M | +180,356 | +$155M |
| AMD - Advanced Micro Devices | 2.56% | New | 4,737,399 | $147.41 | $698M | +4,737,399 | +$698M |
| HDB - Hdfc Bank | 2.39% | Reduce −3.7% | 9,740,785 | $67.11 | $654M | −375,238 | +$57M |
| GE - GE Aerospace | 2.38% | Reduce −36.4% | 5,086,398 | $127.63 | $649M | −2,910,508 | −$235M |
| DE - Deere | 2.06% | New | 1,406,562 | $399.87 | $562M | +1,406,562 | +$562M |
| MA - Mastercard · CL A | 1.81% | Add +295.9% | 1,157,231 | $426.51 | $494M | +864,943 | +$378M |
| BMRN - Biomarin Pharmaceutical | 1.73% | Add +16.0% | 4,889,454 | $96.42 | $471M | +673,998 | +$98M |
| FCX - Freeport-Mcmoran · CL B | 1.72% | Add +13.1% | 11,053,254 | $42.57 | $471M | +1,283,575 | +$106M |
| GOOGL - Alphabet · CL A | 1.69% | New | 3,293,461 | $139.69 | $460M | +3,293,461 | +$460M |
| CBOE - Cboe Global Mkts | 1.58% | New | 2,412,499 | $178.56 | $431M | +2,412,499 | +$431M |
| USB - US Bancorp Del | 1.52% | New | 9,569,638 | $43.28 | $414M | +9,569,638 | +$414M |
| Rayzebio | 1.51% | Hold | 6,642,700 | $62.17 | $413M | — | — |
| TTWO - Take Two | 1.42% | New | 2,412,234 | $160.95 | $388M | +2,412,234 | +$388M |
| LW - Lamb Weston | 1.40% | New | 3,545,376 | $108.09 | $383M | +3,545,376 | +$383M |
| MET - Metlife | 1.36% | Add +91.5% | 5,616,556 | $66.13 | $371M | +2,683,200 | +$187M |
| CBRE - CBRE Group · CL A | 1.30% | Add +52.1% | 3,809,555 | $93.09 | $355M | +1,304,756 | +$170M |
| DASH - Doordash · CL A | 1.26% | Reduce −35.0% | 3,489,066 | $98.89 | $345M | −1,878,456 | −$82M |
| ISRG - Intuitive Surgical | 1.15% | Add +45.3% | 931,484 | $337.36 | $314M | +290,501 | +$127M |
| TMO - Thermo Fisher Scientific | 1.05% | Reduce −40.1% | 538,485 | $530.79 | $286M | −361,230 | −$170M |
| RPRX - Royalty Pharma · CLASS A | 1.04% | Add +6.6% | 10,087,417 | $28.09 | $283M | +623,216 | +$26M |
| Inhibrx | 1.00% | Hold | 7,150,826 | $38.00 | $272M | — | — |
| CPNG - Coupang · CL A | 0.92% | Add +255.2% | 15,494,869 | $16.19 | $251M | +11,132,325 | +$177M |
| UNH - Unitedhealth Group | 0.89% | Reduce −75.2% | 460,782 | $526.47 | $243M | −1,397,162 | −$694M |
| TMUS - T-Mobile US | 0.89% | New | 1,509,999 | $160.33 | $242M | +1,509,999 | +$242M |
| Ginkgo Bioworks · CL A | 0.89% | Hold | 143,085,126 | $1.69 | $242M | — | — |
| EG - Everest Group | 0.84% | Reduce −19.3% | 652,302 | $353.58 | $231M | −156,157 | −$70M |
| ACHC — | 0.80% | Add +24.2% | 2,800,350 | $77.76 | $218M | +545,137 | +$59M |
| FIVN - FIVE9 | 0.78% | Reduce −24.5% | 2,714,117 | $78.69 | $214M | −879,628 | −$18M |
| HCA - Hca Healthcare | 0.72% | New | 725,216 | $270.68 | $196M | +725,216 | +$196M |
| ADPT — | 0.54% | Hold | 29,993,708 | $4.90 | $147M | — | — |
| KBR - KBR Inc | 0.53% | Add +69.4% | 2,633,844 | $55.41 | $146M | +1,078,635 | +$54M |
| Ppg Inds | 0.53% | Reduce −76.0% | 968,866 | $149.55 | $145M | −3,075,378 | −$380M |
| BSX - Boston Scientific | 0.48% | Add +104.2% | 2,267,761 | $57.81 | $131M | +1,157,469 | +$72M |
| CNH - Cnh Indl | 0.44% | Add +46.2% | 9,856,276 | $12.18 | $120M | +3,114,995 | +$38M |
| VVV - Valvoline | 0.44% | Reduce −64.2% | 3,176,309 | $37.58 | $119M | −5,690,854 | −$167M |
| KKR — | 0.42% | New | 1,388,521 | $82.85 | $115M | +1,388,521 | +$115M |
| VEEV - Veeva Sys · CL A | 0.41% | New | 579,753 | $192.52 | $112M | +579,753 | +$112M |
| EPAM - Epam Sys | 0.40% | Reduce −59.9% | 368,708 | $297.34 | $110M | −549,789 | −$125M |
| CSX - CSX Corp | 0.40% | Reduce −70.5% | 3,133,913 | $34.67 | $109M | −7,506,915 | −$219M |
| TEAM - Atlassian · CL A | 0.38% | New | 435,946 | $237.86 | $104M | +435,946 | +$104M |
| PHVS - Pharvaris | 0.38% | Add +13.2% | 3,656,923 | $28.05 | $103M | +425,000 | +$35M |
| RRX - Regal Rexnord | 0.38% | New | 691,717 | $148.02 | $102M | +691,717 | +$102M |
| FDMT — | 0.36% | Hold | 4,787,914 | $20.26 | $97M | — | — |
| KDP - Keurig Dr Pepper | 0.35% | Add +26.2% | 2,886,871 | $33.32 | $96M | +598,610 | +$24M |
| VKTX - Viking Therapeutics | 0.35% | Add +12.5% | 5,145,112 | $18.61 | $96M | +571,796 | +$45M |
| NAMS - Newamsterdam Pharma | 0.33% | Hold | 8,024,565 | $11.17 | $90M | — | — |
| BEKE - KE | 0.31% | Add +14.4% | 5,285,000 | $16.21 | $86M | +665,000 | +$14M |
| LLY - Eli Lilly & | 0.30% | New | 138,728 | $582.92 | $81M | +138,728 | +$81M |
| IFF - International Flavors & Fragrances | 0.28% | Reduce −53.9% | 953,384 | $80.97 | $77M | −1,113,676 | −$64M |
| SYK - Stryker | 0.27% | New | 248,913 | $299.46 | $75M | +248,913 | +$75M |
| EWTX - Edgewise Therapeutics | 0.25% | Hold | 6,159,146 | $10.94 | $67M | — | — |
| CDNS - Cadence Design System | 0.23% | Reduce −86.2% | 228,482 | $272.37 | $62M | −1,424,748 | −$325M |
| ZLAB - Zai Lab | 0.19% | Reduce −25.0% | 1,869,283 | $27.33 | $51M | −621,720 | −$9M |
| MMC - Marsh & Mclennan Cos | 0.16% | New | 237,706 | $189.47 | $45M | +237,706 | +$45M |
| AMLX - Amylyx Pharmaceuticals | 0.16% | Hold | 2,962,555 | $14.72 | $44M | — | — |
| PCOR - Procore Technologies | 0.16% | New | 613,437 | $69.22 | $42M | +613,437 | +$42M |
| DAWNGBX — | 0.14% | Hold | 2,558,563 | $14.60 | $37M | — | — |
| Foot Locker | 0.12% | Reduce −52.0% | 1,073,749 | $31.15 | $33M | −1,161,707 | −$5M |
| Cazoo Group · CL A | 0.07% | New | 2,142,728 | $9.50 | $20M | +2,142,728 | +$20M |
| VSTM - Verastem | 0.07% | Hold | 2,456,292 | $8.14 | $20M | — | — |
| Lianbio | 0.06% | Hold | 3,564,173 | $4.47 | $16M | — | — |
| PEPG - Pepgen | 0.04% | Hold | 1,482,434 | $6.80 | $10M | — | — |
| Rallybio | 0.04% | Hold | 4,194,777 | $2.39 | $10M | — | — |
| TRVI - Trevi Therapeutics | 0.02% | Hold | 4,400,000 | $1.34 | $6M | — | — |
| Kinnate Biopharma | 0.02% | Hold | 1,820,462 | $2.37 | $4M | — | — |
Showing top 50 of 78 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2023 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| MSFT - Microsoft | 3.88% | Exit | 0 | $315.75 | $955M | −3,024,399 | −$955M |
| XYZ - Block · CL A | 2.21% | Exit | 0 | $44.26 | $545M | −12,324,808 | −$545M |
| FTNT - Fortinet | 1.68% | Exit | 0 | $58.68 | $414M | −7,050,550 | −$414M |
| LULU - Lululemon Athletica | 1.22% | Exit | 0 | $385.61 | $299M | −776,515 | −$299M |
| UNM - UNUM Group | 0.95% | Exit | 0 | $49.19 | $235M | −4,778,110 | −$235M |
| AJG - Gallagher Arthur J & | 0.89% | Exit | 0 | $227.93 | $218M | −957,820 | −$218M |
| Karuna Therapeutics | 0.78% | Exit | 0 | $169.09 | $191M | −1,131,263 | −$191M |
| SNPS - Synopsys | 0.57% | Exit | 0 | $458.97 | $141M | −308,059 | −$141M |
| CL - Colgate Palmolive | 0.41% | Exit | 0 | $71.11 | $101M | −1,424,845 | −$101M |
| DOV - Dover | 0.30% | Exit | 0 | $139.51 | $75M | −536,587 | −$75M |
| THC - Tenet Healthcare | 0.27% | Exit | 0 | $65.89 | $68M | −1,025,840 | −$68M |
| GTM - Zoominfo Technologies | 0.25% | Exit | 0 | $16.40 | $62M | −3,754,192 | −$62M |
| DDOG - Datadog · CL A | 0.25% | Exit | 0 | $91.09 | $61M | −668,511 | −$61M |
| Confluent · CLASS A | 0.24% | Exit | 0 | $29.61 | $59M | −1,983,066 | −$59M |
| MBLY - Mobileye Global · CLASS A | 0.17% | Exit | 0 | $41.55 | $42M | −1,011,692 | −$42M |
| DG - Dollar Gen | 0.16% | Exit | 0 | $105.80 | $39M | −368,172 | −$39M |
| ARM — | 0.13% | Exit | 0 | $53.52 | $32M | −600,000 | −$32M |
| Farfetch · CL A | 0.09% | Exit | 0 | $2.09 | $23M | −10,844,009 | −$23M |
| CART - Maplebear | 0.02% | Exit | 0 | $29.69 | $4M | −125,000 | −$4M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 90 | $35.1B | −1.9% | 13F-HR | 8/14/2026 | 000110380426000006 |
| 2026 Q1 | 77 | $35.7B | −5.1% | 13F-HR | 5/15/2026 | 000110380426000004 |
| 2025 Q4 | 76 | $37.7B | −2.1% | 13F-HR | 2/17/2026 | 000110380426000002 |
| 2025 Q3 | 78 | $38.5B | +11.3% | 13F-HR | 11/14/2025 | 000110380425000010 |
| 2025 Q2 | 83 | $34.6B | +9.9% | 13F-HR | 8/14/2025 | 000110380425000007 |
| 2025 Q1 | 91 | $31.5B | +1.9% | 13F-HR | 5/15/2025 | 000110380425000004 |
| 2024 Q4 | 86 | $30.9B | +12.6% | 13F-HR | 2/14/2025 | 000110380425000002 |
| 2024 Q3 | 83 | $27.4B | +5.4% | 13F-HR | 11/14/2024 | 000110380424000006 |
| 2024 Q2 | 82 | $26B | −3.1% | 13F-HR | 8/14/2024 | 000090514824002226 |
| 2024 Q1 | 83 | $26.9B | −1.6% | 13F-HR | 5/15/2024 | 000110380424000004 |
| 2023 Q4 | 79 | $27.3B | +10.8% | 13F-HR | 2/14/2024 | 000110380424000002 |
| 2023 Q3 | 80 | $24.6B | +0.9% | 13F-HR | 11/14/2023 | 000110380423000009 |
| 2023 Q2 | 86 | $24.4B | +14.6% | 13F-HR | 8/14/2023 | 000110380423000006 |
| 2023 Q1 | 81 | $21.3B | +6.7% | 13F-HR | 5/15/2023 | 000110380423000004 |
| 2022 Q4 | 76 | $20B | −7.8% | 13F-HR | 2/14/2023 | 000110380423000002 |
| 2022 Q3 | 88 | $21.7B | −0.9% | 13F-HR | 11/14/2022 | 000110380422000006 |
| 2022 Q2 | 82 | $21.9B | −11.6% | 13F-HR | 8/15/2022 | 000110380422000004 |
| 2022 Q1 | 91 | $24.7B | −28.3% | 13F-HR | 5/16/2022 | 000110380422000003 |
| 2021 Q4 | 107 | $34.7B | — | RESTATEMENT | 5/16/2022 | 000156761922010954 |
| 2021 Q4 | 107 | $34.5B | −4.3% | 13F-HR | 2/14/2022 | 000110380422000002 |
| 2021 Q3 | 96 | $36.5B | — | RESTATEMENT | 5/16/2022 | 000156761922010950 |
| 2021 Q3 | 96 | $36B | — | 13F-HR | 11/15/2021 | 000110380421000009 |
About
VIKING GLOBAL INVESTORS LP
22 processed 13Fs on this site · 2021 Q3–2026 Q2